| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |